NKTR
Price
$1.39
Change
+$0.06 (+4.51%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
NTLA
Price
$15.44
Change
+$0.30 (+1.98%)
Updated
Nov 5, 04:00 PM (EDT)
2 days until earnings call
Ad is loading...

NKTR vs NTLA

Header iconNKTR vs NTLA Comparison
Open Charts NKTR vs NTLABanner chart's image
Nektar Therapeutics
Price$1.39
Change+$0.06 (+4.51%)
Volume$300.64K
CapitalizationN/A
Intellia Therapeutics
Price$15.44
Change+$0.30 (+1.98%)
Volume$252.41K
CapitalizationN/A
View a ticker or compare two or three
NKTR vs NTLA Comparison Chart
Loading...
NKTR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NKTR vs. NTLA commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTR is a StrongBuy and NTLA is a Sell.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (NKTR: $1.34 vs. NTLA: $15.15)
Brand notoriety: NKTR: Notable vs. NTLA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTR: 479% vs. NTLA: 83%
Market capitalization -- NKTR: $257.71M vs. NTLA: $1.57B
NKTR [@Biotechnology] is valued at $257.71M. NTLA’s [@Biotechnology] market capitalization is $1.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $488.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTR’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • NKTR’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTR is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTR’s TA Score shows that 6 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • NKTR’s TA Score: 6 bullish, 3 bearish.
  • NTLA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than NTLA.

Price Growth

NKTR (@Biotechnology) experienced а -1.47% price change this week, while NTLA (@Biotechnology) price change was -7.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.79%. For the same industry, the average monthly price growth was +15.00%, and the average quarterly price growth was +10.61%.

Reported Earning Dates

NKTR is expected to report earnings on Feb 27, 2025.

NTLA is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.54B) has a higher market cap than NKTR($247M). NKTR YTD gains are higher at: 137.168 vs. NTLA (-50.312). NKTR has higher annual earnings (EBITDA): -146.03M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. NKTR (271M). NTLA has less debt than NKTR: NTLA (106M) vs NKTR (112M). NKTR has higher revenues than NTLA: NKTR (93.2M) vs NTLA (46M).
NKTRNTLANKTR / NTLA
Capitalization247M1.54B16%
EBITDA-146.03M-514.18M28%
Gain YTD137.168-50.312-273%
P/E RatioN/AN/A-
Revenue93.2M46M203%
Total Cash271M691M39%
Total Debt112M106M106%
FUNDAMENTALS RATINGS
NKTR vs NTLA: Fundamental Ratings
NKTR
NTLA
OUTLOOK RATING
1..100
726
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
4491
P/E GROWTH RATING
1..100
87100
SEASONALITY SCORE
1..100
3150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTLA's Valuation (33) in the Biotechnology industry is in the same range as NKTR (58). This means that NTLA’s stock grew similarly to NKTR’s over the last 12 months.

NTLA's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as NKTR (100). This means that NTLA’s stock grew similarly to NKTR’s over the last 12 months.

NTLA's SMR Rating (96) in the Biotechnology industry is in the same range as NKTR (98). This means that NTLA’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's Price Growth Rating (44) in the Biotechnology industry is somewhat better than the same rating for NTLA (91). This means that NKTR’s stock grew somewhat faster than NTLA’s over the last 12 months.

NKTR's P/E Growth Rating (87) in the Biotechnology industry is in the same range as NTLA (100). This means that NKTR’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NKTRNTLA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
NKTR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRCRX10.280.11
+1.08%
NYLI CBRE Real Estate Class C
NTIAX15.620.04
+0.26%
Columbia Mid Cap Index A
FBOGX10.000.02
+0.20%
Templeton Global Smaller Comp R6
JGASX40.48-0.16
-0.39%
JPMorgan Growth Advantage I
RYLDX169.06-2.11
-1.23%
Rydex Dow 2x Strategy A

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with DNLI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
+8.94%
DNLI - NKTR
43%
Loosely correlated
+0.59%
NTLA - NKTR
43%
Loosely correlated
+2.30%
SLS - NKTR
42%
Loosely correlated
-2.10%
MDGL - NKTR
38%
Loosely correlated
+3.67%
ATAI - NKTR
37%
Loosely correlated
+0.46%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with BEAM. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+2.30%
BEAM - NTLA
69%
Closely correlated
+6.24%
VCYT - NTLA
69%
Closely correlated
+2.07%
EDIT - NTLA
68%
Closely correlated
-1.03%
CRSP - NTLA
64%
Loosely correlated
-0.28%
PRME - NTLA
59%
Loosely correlated
-1.49%
More